sever
acut
respiratori
syndrom
sar
highli
contagi
infecti
diseas
first
emerg
late
caus
novel
human
coronaviru
sar
coronaviru
sarscov
viru
believ
origin
bat
transmit
human
intermedi
anim
civet
cat
reemerg
sarscov
remain
valid
concern
due
continu
persist
zoonot
sarscov
sarslik
cov
slcov
bat
reservoir
studi
screen
presenc
sarsspecif
cell
cohort
three
sarsrecov
individu
year
postinfect
carri
memori
cell
respons
detect
target
sarscov
structur
protein
two
cell
respons
target
sarscov
membran
nucleocapsid
n
protein
character
determin
hla
restrict
minim
cell
epitop
region
furthermor
respons
found
persist
year
postinfect
absenc
crossreact
cell
respons
newlyemerg
middl
east
respiratori
syndrom
coronaviru
merscov
also
demonstr
knowledg
persist
sarsspecif
celullar
immun
target
viral
structur
protein
sarsrecov
individu
import
design
develop
sar
vaccin
current
unavail
sever
acut
respiratori
syndrom
sar
first
emerg
year
ago
highli
contagi
infecti
diseas
caus
novel
human
coronaviru
term
sar
coronaviru
sarscov
viru
spread
countri
short
period
three
month
affect
total
peopl
global
includ
death
fatal
rate
sarscov
believ
origin
bat
transmit
human
intermedi
anim
civet
cat
although
sar
case
report
sinc
reemerg
sarscov
public
health
concern
due
continu
persist
sarscov
accessori
protein
protein
anim
studi
indic
import
cell
clearanc
sarscov
primari
infect
protect
diseas
human
decreas
cell
number
lymphopenia
correl
sever
diseas
indic
critic
role
cellmedi
immun
respons
diseas
develop
sarsspecif
antibodi
level
sarsrecov
individu
undetect
year
postinfect
sarsspecif
memori
cell
persist
year
follow
recoveri
longterm
persist
memori
cell
immun
could
import
protect
sarscov
reinfect
studi
presenc
sarsspecif
cell
screen
three
sarsrecov
individu
year
postinfect
character
cell
respons
structur
n
protein
carri
includ
determin
hla
restrict
minim
cell
epitop
addit
crossreact
sarsspecif
cell
middl
east
respiratori
syndrom
coronaviru
merscov
investig
total
peptid
purchas
chiron
mimotop
victoria
australia
puriti
composit
confirm
mass
spectrometri
peptid
overlap
residu
span
proteom
sarscov
structur
e
n
accessori
protein
peptid
receiv
lyophil
form
dilut
mgml
dimethyl
sulfoxid
dmso
dilut
rpmi
medium
gibco
work
concentr
mgml
mgml
three
sarsrecov
individu
enrol
singapor
gener
hospit
singapor
particip
diagnos
sar
period
accord
world
health
organ
definit
sar
blood
sampl
obtain
either
year
postinfect
studi
approv
singhealth
central
institut
review
board
singapor
peripher
blood
mononuclear
cell
pbmc
isol
fresh
heparin
blood
densiti
gradient
centrifug
use
ficollpaqu
tm
ge
life
scienc
resuspend
aimv
medium
invitrogen
pool
human
ab
serum
aimv
ab
cell
either
frozen
use
directli
vitro
expans
presenc
sar
peptid
previous
describ
antihuman
enzymelink
immunospot
elispot
assay
perform
previous
describ
use
sar
peptid
arrang
numer
alphabet
matrix
pool
supplementari
tabl
posit
threshold
set
number
spotform
unit
sfu
per
cell
least
twice
observ
neg
control
cell
stimul
peptid
peptid
respons
posit
elispot
result
identifi
common
peptid
present
numer
alphabet
pool
vitro
expand
pbmc
incub
aimv
ab
medium
alon
peptid
gml
h
presenc
gml
brefeldin
antibodi
bd
pharmingen
ad
assess
cell
degranul
posit
control
consist
cell
incub
aimv
ab
ngml
phorbol
pma
ngml
ionomycin
follow
stimul
cell
wash
hank
balanc
salt
solut
hbss
gibco
stain
pe
chlorophyl
protein
percp
bd
pharmingen
c
cell
wash
phosphat
buffer
salin
pb
contain
bsa
azid
fix
permeabil
use
cytofixcytoperm
fixationpermeabil
reagent
bd
bioscienc
accord
manufactur
protocol
intracellular
stain
use
bd
pharmingen
carri
c
follow
wash
flow
cytometri
analysi
hla
class
phenotyp
sarsrecov
subject
determin
pcr
amplif
sequencingbas
type
method
previous
describ
perform
bgi
clinic
laboratori
shenzhen
china
epsteinbarr
virustransform
lymphoblastoid
b
cell
line
ebvlcl
possess
match
hla
phenotyp
subject
use
antigenpres
cell
apc
determin
hla
restrict
cell
respons
restimul
sarsspecif
cell
done
use
fresh
pbmc
healthi
donor
ebvlcl
consist
hla
allel
restrict
cell
respons
specif
peptid
ad
ebvlcl
gml
medium
incub
c
h
follow
wash
hbss
pbmc
peptidepuls
ebvlcl
irradi
rad
rad
respect
wash
hbss
ad
vitro
expand
cell
aimv
ab
supplement
uml
ngml
ngml
cocultur
c
day
map
minim
cell
epitop
restimul
shortterm
cell
line
test
truncat
peptid
peptid
ic
minim
epitop
map
peptid
span
region
test
minim
epitop
map
peptid
span
overlap
region
use
current
unknown
sarsspecif
memori
cell
respons
persist
sarsrecov
individu
year
postinfect
pbmc
sar
convalesc
subject
sar
subject
collect
year
postinfect
test
sarsspecif
memori
cell
neg
control
pbmc
healthi
individu
sar
histori
also
obtain
test
vitro
expans
mixtur
sar
peptid
overlap
residu
span
structur
e
n
accessori
protein
pbmc
subject
elispot
assay
use
sar
peptid
pool
arrang
alphabet
numer
matic
supplementari
tabl
analysi
elispot
result
perform
posit
threshold
set
number
spotform
unit
sfu
two
time
mean
sfu
unstimul
cell
shown
fig
higher
frequenc
sfu
observ
vitroexpand
pbmc
sar
subject
compar
healthi
individu
suggest
presenc
sarsspecif
memori
cell
year
postinfect
respons
low
frequenc
sinc
vitro
expans
pbmc
requir
detect
agreement
previou
report
report
declin
memori
cell
respons
sar
convalesc
individu
time
peptid
induc
product
identifi
elispot
test
ic
confirm
abil
elicit
specif
cell
respons
defin
subset
cell
involv
total
sarsspecif
memori
cell
respons
vitro
use
mixtur
sarscov
peptid
follow
elispot
assay
use
sar
peptid
matrix
pool
structur
top
panel
accessori
protein
lower
panel
bar
repres
respons
individu
peptid
matrix
pool
numer
alphabet
sfu
per
cell
threshold
posit
respons
set
two
time
mean
sfu
unstimul
cell
neg
indic
dot
line
right
panel
cell
stimul
pmaionomycin
includ
posit
control
po
identifi
sar
subject
specif
structur
n
protein
tabl
three
cell
respons
two
recogn
protein
one
recogn
n
protein
addit
memori
cell
respons
specif
sarscov
protein
detect
subsequ
pbmc
obtain
two
sarsrecov
individu
sar
subject
year
postinfect
respect
screen
sarsspecif
memori
cell
use
method
memori
cell
respons
specif
sarscov
structur
protein
also
found
tabl
observ
sar
subject
respons
respons
found
sar
subject
respect
sar
subject
also
possess
cell
respons
target
summar
tabl
subject
sarsspecif
memori
cell
higher
frequenc
compar
two
subject
note
subject
sever
diseas
present
supplementari
tabl
could
relat
robust
cell
respons
detect
howev
number
subject
recruit
studi
small
draw
conclus
correl
knowledg
sarscov
structur
protein
highli
immunogen
elicit
protect
immunodomin
cell
respons
wellestablish
cell
epitop
identifi
specif
protein
residu
protein
residu
protein
residu
n
protein
residu
previous
report
cohort
sarsrecov
patient
year
postinfect
suggest
immunopreval
domin
respons
convalesc
sar
patient
identif
cell
respons
sarscov
structur
n
protein
year
postinfect
suggest
longterm
persist
respons
cell
respons
present
sar
subject
specif
sar
peptid
correspond
residu
structur
protein
character
use
cell
subject
cell
respons
determin
restrict
hlab
allel
reveal
ic
cell
exhibit
respons
stimul
peptid
fig
left
panel
addit
express
cell
induc
peptid
determin
fig
right
panel
increas
express
marker
cell
degranul
target
cellkil
function
via
perforingranzym
pathway
indic
memori
cell
capabl
degranul
like
exhibit
target
cellkil
function
upon
activ
peptid
tabl
summari
cell
respons
sarsrecov
subject
year
postinfect
identifi
screen
elispot
confirm
ic
percentag
cell
respons
repres
cell
total
cell
popul
vitro
expans
presenc
sar
peptid
mixtur
hla
class
molecul
preferenti
bind
present
peptid
amino
acid
recogn
hla
receptor
cell
cell
activ
sinc
peptid
peptid
identif
posit
minim
number
amino
acid
within
region
known
minim
epitop
capabl
elicit
cell
respons
carri
truncat
peptid
within
region
rang
test
abil
induc
secret
cell
shown
tabl
peptid
correspond
residu
protein
effici
induc
cell
respons
result
highest
percentag
cell
also
repres
minim
epitop
cell
respons
remov
either
nterminu
histidin
h
residu
cterminu
leucin
l
residu
complet
abolish
product
tabl
studi
involv
sar
convalesc
patient
year
postinfect
cell
respons
residu
protein
present
studi
subject
minim
epitop
hlarestrict
respons
determin
minim
epitop
residu
identifi
present
studi
lie
within
report
region
cell
epitop
within
sarscov
protein
also
report
anoth
studi
look
sarsspecif
memori
cell
respons
sarsrecov
individu
year
postinfect
present
cell
respons
peptid
support
role
protein
elicit
domin
cellular
immun
sarscov
infect
sarscov
n
protein
capabl
induc
immunodomin
cell
respons
sarsrecov
individu
respons
shown
involv
diseas
protect
anim
model
previou
studi
perform
year
postsar
sever
sarsspecif
cell
epitop
within
n
protein
report
sar
subject
year
postinfect
hlab
memori
cell
respons
target
peptid
correspond
residu
n
protein
detect
determin
minim
epitop
cell
respons
truncat
peptid
test
induct
cell
respons
use
pbmc
sar
subject
previous
collect
year
postinfect
truncat
peptid
consist
within
overlap
residu
peptid
peptid
also
capabl
induc
tabl
summari
percentag
respons
sar
subject
induc
truncat
peptid
within
region
cell
use
obtain
sar
subject
year
postinfect
result
posit
peptid
select
neg
peptid
shown
percentag
cell
shown
repres
percentag
cell
total
cell
popul
gate
cell
present
shortterm
cell
line
obtain
restimul
use
peptid
minim
epitop
indic
ital
peptid
tabl
summari
percentag
respons
sar
subject
induc
truncat
peptid
within
region
cell
use
obtain
sar
subject
year
postinfect
percentag
cell
shown
repres
percentag
cell
total
cell
popul
gate
cell
present
shortterm
cell
line
obtain
restimul
use
peptid
minim
epitop
indic
ital
respons
data
shown
found
peptid
correspond
residu
n
protein
effici
induc
cell
respons
tabl
delet
ntermin
threonin
residu
ctermin
phenylalanin
f
residu
led
decreas
percentag
cell
respect
indic
residu
minim
epitop
cell
respons
previou
studi
use
bioinformat
netmhcpan
algorithm
predict
minim
epitop
respons
determin
amino
acid
posit
within
region
identifi
current
studi
thu
far
studi
report
identif
cell
epitop
character
two
cell
respons
year
postinfect
donor
recal
year
postinfect
determin
persist
respons
pbmc
collect
individu
expand
vitro
use
minim
peptid
test
respons
shown
fig
left
panel
cell
stimul
peptid
cell
respons
observ
respect
suggest
persist
sarsspecif
memori
cell
year
infect
express
also
observ
cell
stimul
peptid
respect
fig
right
panel
indic
degranul
cell
upon
peptid
stimul
howev
cell
respons
detect
sar
subject
year
postinfect
tabl
undetect
year
postinfect
data
shown
novel
human
coronaviru
merscov
first
emerg
like
sarscov
merscov
betacoronaviru
caus
seriou
sometim
fatal
lower
respiratori
tract
infect
extrapulmonari
manifest
contrari
sarscov
lineag
b
betacoronaviru
merscov
belong
lineag
c
investig
sarsspecif
cell
crossreact
n
peptid
merscov
sequenc
align
done
identifi
correspond
minim
epitop
merscov
fig
b
cell
stimul
merscov
minim
epitop
peptid
hlkmagmhf
minim
epitop
peptid
tksfnmvqaf
respons
observ
fig
indic
inabl
sarsspecif
cell
activ
merscov
peptid
therefor
cell
immun
sarscov
highli
specif
cell
respons
unlik
provid
crossprotect
merscov
infect
expect
merscov
distantli
relat
sarscov
close
relat
bat
coronavirus
nonetheless
sequenc
align
reveal
minim
epitop
fulli
conserv
human
zoonot
strain
fig
b
includ
civet
sarscov
bat
slcov
bat
sarscov
capabl
util
human
bat
receptor
cell
entri
henc
like
sarsspecif
cell
confer
crossprotect
infect
zoonot
sarscov
slcov
strain
current
report
persist
memori
cell
sarsrecov
individu
beyond
year
postinfect
therefor
longev
sarscov
cellular
immun
unclear
studi
demonstr
sarsspecif
memori
cell
persist
three
sarsrecov
individu
year
postsar
absenc
antigen
memori
cell
detect
specif
sarscov
structur
n
protein
two
immunodomin
cell
respons
specif
n
protein
character
defin
minim
epitop
hla
restrict
cell
respons
continu
persist
sarsrecov
subject
year
postinfect
persist
cell
respons
suggest
sarsrecov
patient
could
protect
reinfect
peptid
replicas
protein
compris
sarscov
proteom
includ
memori
cell
screen
current
studi
due
limit
amount
sar
subject
pbmc
obtain
howev
base
current
literatur
sarscov
replicas
protein
less
immunogen
compar
structur
protein
also
note
avail
three
convalesc
individu
signific
constraint
studi
futur
studi
conclus
drawn
could
substanti
includ
sarsrecov
subject
phase
clinic
trial
involv
sar
dna
vaccin
encod
protein
sarsspecif
cell
respons
observ
vaccin
individu
suggest
protein
suffici
induc
cell
respons
line
result
current
studi
show
longterm
persist
cell
respons
target
protein
well
structur
protein
includ
n
protein
provid
evid
design
sar
vaccin
compris
viral
structur
protein
induct
domin
potent
longliv
memori
cellular
respons
viru
